Literature DB >> 30113202

Subjective well-being differs with age in multiple sclerosis: A brief report.

Brocha Z Stern1, Lauren Strober2, John DeLuca2, Yael Goverover1.   

Abstract

OBJECTIVE: Increased age is associated with improved subjective well-being in the general population. However, there are conflicting findings regarding this association in individuals with multiple sclerosis (MS). In the present study, we examined differences in depression and quality of life (QOL) among 3 age groups of individuals with MS.
METHOD: Participants consisted of 57 individuals with MS who were divided into 3 age groups: 35-44, 45-54, and 55-65 years. Outcome measures included the Mood and Evaluative scale t scores on the Chicago Multiscale Depression Inventory (CMDI) and the Physical and Mental scale scores on the Multiple Sclerosis Quality of Life Instrument (MSQOL-54).
RESULTS: After controlling for disease duration, individuals in the oldest group reported significantly less severe depressive symptoms and better physical QOL than the youngest group.
CONCLUSIONS: Results are consistent with theoretical predictions and observations of improved subjective well-being with age in the general population. Younger individuals with MS may be at higher risk for depression and poor QOL. Additional research is needed to model the findings in larger samples and clarify the theoretical mechanisms of the observed associations. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Year:  2018        PMID: 30113202     DOI: 10.1037/rep0000220

Source DB:  PubMed          Journal:  Rehabil Psychol        ISSN: 0090-5550


  4 in total

1.  Anxiety and depression in Multiple Sclerosis (MS): Antecedents, consequences, and differential impact on well-being and quality of life.

Authors:  Mariam Hanna; Lauren Beth Strober
Journal:  Mult Scler Relat Disord       Date:  2020-06-06       Impact factor: 4.339

2.  The Influence of Self-Perception on Manipulative Dexterity in Adults with Multiple Sclerosis.

Authors:  Rosa M Martínez-Piédrola; Cristina García-Bravo; Elisabet Huertas-Hoyas; Patricia Sánchez-Herrera Baeza; Jorge Pérez-Corrales; Carlos Sánchez-Camarero; Marta Pérez-de-Heredia-Torres
Journal:  Occup Ther Int       Date:  2021-08-16       Impact factor: 1.448

3.  Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases.

Authors:  Eun-Jae Lee; Young-Min Lim; Seungmi Kim; Lynkyung Choi; Hyunjin Kim; Keonwoo Kim; Hye Weon Kim; Ji Sung Lee; Kwang-Kuk Kim
Journal:  Ann Clin Transl Neurol       Date:  2020-06-04       Impact factor: 4.511

4.  Quality of life in adults with multiple sclerosis: a systematic review.

Authors:  Irene Gil-González; Agustín Martín-Rodríguez; Rupert Conrad; María Ángeles Pérez-San-Gregorio
Journal:  BMJ Open       Date:  2020-11-30       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.